polycystic kidney disease
autosomal dominant polycystic kidney disease (ADPKD) is one of the most common inherited disorders in humans affecting ~ 0.1% of the population, but does not usually present until middle age
2 main autosomal dominant genetic causes but with wide clinical variability even within families:
PKD1 codes for polycystin 1 and is located on 16p13.3 and accounts for most ADPKD cases and is the more severe form with mean age of end stage renal disease (ESRD) for patients with ADPKD1 is 53 years
PKD2 codes for polycystin 2 is located on 4q21-q22 and accounts for 15% of ADPKD cases with mean age of ESRD for patients with ADPKD1 is 74 years
the most frequent genetic cause of renal failure in adults and accounts for 6-8% of patients on dialysis
clinical features usually begin in the third to fourth decade of life but some may have cysts in utero.
it appears that an additional renal insult is needed to spur development of the cysts such as urolithiasis
diagnosis cannot be reliably excluded until at least age 50yrs or so when absence of renal cysts is highly suggestive the patient does not have this condition.
animal models implicate argipressin (vasopressin / ADH)
as promoter of kidney cyst cell proliferation and luminal fluid secretion, hence a trial of the vasopressin antagonist
, tolvaptan, was undertaken and appears to show substantial benefit, although 25% discontinued Rx due to adverse effects.
other DDx of renal cysts
risk factors for progression of ADPKD to ESRD
clinical features of ADPKD
polycystic_kidney.txt · Last modified: 2019/08/28 00:33 (external edit)